Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.
Myricx Pharma has raised €5.0M across 1 funding round, most recently a Seed round in Nov 2020. Based in Stevenage, UK; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-11-16 | Seed | €5.0M |
| — |
| View deal → |
